Global Healthcare CMO Market (2018-2022 Edition)
- Report Description Table of Contents
Scope of the Report
This report named “Global Healthcare CMO Market (2018-2022 Edition)”, analysis the growth and sizing of global healthcare CMO market and its segments. This report provides the analysis of global healthcare CMO market by value and by segment.
The analysis of global medical device CMO market is done by value, by players and by cost structure and analysis of global pharmaceutical CMO is done by value and by segments. The global pharmaceutical CMO market by segments is analyzed in detail by providing analysis of each of its segment.
This report includes the analysis of global active pharmaceutical ingredient CMO market by value and analysis of finished dosage formulation CMO market by value, by revenue structure, by geographical approach and by dosage formulation.
This report also provides the analysis of global pharmaceutical CDMO market. This analysis includes the global pharmaceutical CDMO market by value, by players and by geography. The regional analysis of global pharmaceutical CDMO market is also done in this report. The regions included are United States of America, Europe, China and India.
This report also includes the growth drivers, market trends and challenges faced by global healthcare CMO market. Company profiling of major players of healthcare CMO industry is also done in this report. The companies included are Catalent Pharma Solution, Recipharm, Aurobindo Pharma Ltd. and Boehringher Ingelheim. Business overview, financial overview and business strategy for each company is provided.
- Catalent Pharma Solution
- Aurobindo Pharma Ltd.
- Boehringher Ingelheim
- The US
Contract manufacturing is a type of outsourcing in which a firm contacts with a third party (contract manufacturing organization) for the manufacturing of components of its product or whole of its product. A contract manufacturing organization (CMO) undertakes the production of product(s) under the brand name of another firm.
A big or a mid-sized firm opt for a CMO mainly for two reasons, either it wants to shift (or reduce) its cost and focus to its core activities, or the manufacturing of its products require special or expert handling.
CMOs provide independent manufacturing services in healthcare sector also. Healthcare CMOs can be segmented into pharmaceutical CMOs and medical device CMOs. After the discovery of chemical formula of a new drug, the pharmaceutical CMOs are given the task of manufacturing it into a whole product, so that the pharmaceutical companies are able to sell it into the market under their brand name. Services offered by pharmaceutical CMOs can be divided into two main activities: primary manufacturing (Active Pharmaceutical Ingredients) and secondary manufacturing (Finished Dosage Formulation). Contract manufacturing for medical devices is one of the fastest growing segments of the medical device industry, as companies are in the race to bring new devices to the market.
From last few years, many pharmaceutical CMOs have included development part into their activities, apart from manufacturing of drugs and they are called contract development & manufacturing organizations (CDMOs). The market for pharmaceutical CMOs and CDMOs can neither be taken as same, nor be taken as completely distinct from each other. Also, these two markets cannot be combined together, as it will exaggerate the global pharmaceutical CMO market.
The global healthcare CMO market has recorded a continuous growth since last few years and is expected to follow the same trend in coming years. The main driving factors for this growth are rise in global pharmaceutical industry, increased need for outsourcing, increased approvals and outsourcing of NMEs, innovations and increased regulatory pressure on quality. Yet there are some challenges, which healthcare CMO industry faces, such as fragmented nature of market, less preference for outsourcing of profitable and biological drugs by big pharmaceutical companies.